VICP Registry Case Source Bundle
Canonical URL: https://vicp-registry.org/case/USCOURTS-cofc-1_22-vv-01878
Package ID: USCOURTS-cofc-1_22-vv-01878
Petitioner: Dawn Strong
Filed: 2025-02-19
Decided: 2025-05-02
Vaccine: Influenza
Vaccination date: 2020-01-15
Condition: Steven Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN)
Outcome: compensated
Award amount USD: 330000

AI-assisted case summary:
Dawn Strong filed a petition for compensation under the National Vaccine Injury Compensation Program, alleging she suffered from Steven Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) as a result of the Influenza, Hepatitis B, MMR, Tdap/Pertussis, and Varicella vaccinations she received on January 15-16, 2020. The respondent, the Secretary of Health and Human Services, denied that the vaccines caused Petitioner's conditions. Despite maintaining their positions, both parties entered into a joint stipulation to settle the case and award compensation. The court reviewed the stipulation and found it to be reasonable, adopting it as its decision. The award includes a lump sum of $100,000.00 for first-year life care expenses, lost earnings, pain and suffering, and past unreimbursable expenses. Additionally, $230,000.00 was awarded to purchase an annuity contract, covering all damages available under the program. The decision was issued on May 2, 2025, following the petition filed on February 19, 2025.

Theory of causation field:
unclear

Public staged source text:

================================================================================
DOCUMENT 1: USCOURTS-cofc-1_22-vv-01878-0
Date issued/filed: 2025-05-02
Pages: 10
Docket text: PUBLIC DECISION (Originally filed: 2/19/2025) regarding 43 DECISION of Special Master - Stipulation. Signed by Special Master Jennifer A. Shah. (sl) Service on parties made.
--------------------------------------------------------------------------------
Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 1 of 10
In the United States Court of Federal Claims
OFFICE OF SPECIAL MASTERS
No. 22-1878V
* * * * * * * * * * * * * * * * * * * * * * * * * *
*
*
DAWN STRONG,
*
* UNPUBLISHED
Petitioner, *
*
*
v.
*
* Filed: February 19, 2025
SECRETARY OF HEALTH AND *
HUMAN SERVICES, *
*
*
Respondent. *
*
* * * * * * * * * * * * * * * * * * * * * * * * * *
Kelly Elizabeth Elder, Martin & Jones, PLLC, Raleigh, NC, for Petitioner
Julia Marter Collison, U.S. Department of Justice, Washington, DC, for Respondent
DECISION ON JOINT STIPULATION1
On December 20, 2022, Dawn Strong (“Petitioner”) filed a petition, seeking compensation
under the National Vaccine Injury Compensation Program (“the Vaccine Program”).2 Pet., ECF
No. 1. Petitioner alleges she suffered from Steven Johnson Syndrome (“SJS”) and Toxic
Epidermal Necrolysis (“TEN”) as a result of the Influenza, Hepatitis B, MMR, TD, Tdap/Pertussis,
1 Although this Decision has been formally designated “not to be published,” it will nevertheless be posted
on the Court of Federal Claims’ website in accordance with the E-Government Act of 2002, 44 U.S.C. §
3501 (2012). This means the Decision will be available to anyone with access to the internet. As
provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the Decision’s inclusion of
certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen
days within which to request redaction “of any information furnished by that party: (1) that is a trade secret
or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files
or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.”
Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id.
2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L.
No. 99-660, 100 Stat. 3755 (codified as amended at 42 U.S.C. §§ 300aa-10–34 (2012)) (hereinafter
“Vaccine Act” or “the Act”). All subsequent references to sections of the Vaccine Act shall be to the
pertinent subparagraph of 42 U.S.C. § 300aa.

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 2 of 10
and Varicella vaccinations she received on January 15-16, 2020.3 See Stipulation ¶ 2, 4, dated
February 19, 2025 (ECF No. 42); see also Petition.
Respondent denies “that the vaccines caused petitioner to suffer from SJS and TEN or any
other injury or her current condition.” See Stipulation ¶ 6. Nonetheless, both parties, while
maintaining their above-stated positions, agreed in a stipulation filed February 19, 2025, that the
issues before them can be settled and that a decision should be entered awarding Petitioner
compensation.
I have reviewed the file, and based upon that review, I conclude that the parties’ stipulation
is reasonable. I therefore adopt it as my decision in awarding damages on the terms set forth
therein.
The stipulation awards:
1. A lump sum of $100,000.00, which amount represents compensation for a portion of
petitioner’s first year life care expenses and combined lost earnings, pain and
suffering and past unreimbursable expenses, to be paid through an ACH deposit to
petitioner’s counsel’s IOLTA account for prompt disbursement to petitioner.
2. An amount of $230,000.00 to purchase the annuity contract described in paragraph 10
of the Stipulation, paid to the life insurance company from which the annuity will be
purchased (the "Life Insurance Company").
3. An amount sufficient to purchase the annuity contract described in paragraph 11 of
the Stipulation, paid to the life insurance company from which the annuity will be
purchased (the "Life Insurance Company").
Stipulation ¶ 8. This award represents compensation for all damages that would be available under
42 U.S.C. § 300aa-15(a).
I approve a Vaccine Program award in the amount set forth above to be made to Petitioner.
In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of the Court
is directed to enter judgment herewith.4
IT IS SO ORDERED.
s/ Jennifer A. Shah
Jennifer A. Shah
Special Master
3 The stipulation notes that Petitioner received a single Tdap vaccine, not “TD” and “Tdap/Pertussis”
vaccines, as alleged in the petition. Stipulation at 1.
4 Pursuant to Vaccine Rule 11(a), the parties may expedite entry of judgment by jointly filing notice
renouncing their right to seek review.

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 3 of 10

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 4 of 10

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 5 of 10

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 6 of 10

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 7 of 10

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 8 of 10

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 9 of 10

Case 1:22-vv-01878-UNJ Document 47 Filed 05/02/25 Page 10 of 10